# Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer

> **NCT03843229** · PHASE4 · UNKNOWN · sponsor: **The First Affiliated Hospital of Dalian Medical University** · enrollment: 90 (estimated)

## Conditions studied

- Liver Cancer

## Interventions

- **DRUG:** Cinobufacini injection
- **PROCEDURE:** Transarterial Chemoembolization(TACE)
- **DRUG:** cinobufacini tablet

## Key facts

- **NCT ID:** NCT03843229
- **Lead sponsor:** The First Affiliated Hospital of Dalian Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-27
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2019-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03843229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03843229, "Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03843229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*